Scientists Spread of Prostate Cancer: Magali Williamson. Magali Williamson was awarded a BSc from Imperial College and a PhD from the Institute of Child Health. She worked as a postdoctoral research fellow at the Marie Curie Research Institute on the molecular genetics of bladder cancer, and then at the Department of Paediatrics, UCL. In 2000 she became a lecturer at UCL, working at the PCRC on the spread of prostate cancer, moving to KCL in 2014. Boris Shorning. Boris works at Cardiff University on the PCRC-funded project, investigating the role of Plexin B1 in the spread of prostate cancer. He is interested in biochemical pathways involved in the development and spread of cancer. Boris is originally from Volgograd, Russia, he did his PhD in Moscow and he worked at Edinburgh University before coming to Cardiff. Anne Ridley. Anne Ridley was awarded a BA from Cambridge, a PhD from the University of London and an EMBO fellowship to work at MIT, Cambridge, USA. After working at the ICR and the Ludwig, she became Professor of Cell Biology at KCL. Her team investigates how prostate cancer cells spread through the bloodstream, and how to inhibit this process by reducing prostate cancer cell attachment to endothelial cells that line blood vessels. Prostate Cancer Stem Cells: Dr Aamir Ahmed. Dr Aamir Ahmed was awarded a PhD from Dundee and has worked at Yale University, the University of Florida and University College London. He received an ESPEN-Ajinomoto Research Fellowship and a Wellcome Trust Fellowship. His PCRC funded research at KCL focusses on prostate cancer stem cells. The current members of Aamir’s research group include: Ms Marta Reyes-Corral, a Biomedical Research Centre/King’s College London Ph D fellow, is investigating the mechanisms of Wnt signaling in prostate cancer. Ms Reyes-Corral graduated from Seville, Spain and part of the course was conducted at the University of Richmond, Virginia, USA. She moved to King’s College London to conduct an MRes at the Department of Developmental Neurobiology. This was followed by a successful application to a highly competitive MRes/PhD Programme in Biomedical and Translational Science funded by the Biomedical Research Centre and King’s College. She is now conducting her PhD research with Dr Aamir Ahmed to target Wnt signaling for prostate cancer therapies. Mr Terry Petrou a post-graduate student is receiving research training in new techniques to investigate novel compounds to treat prostate cancer. Mr Petrou moved from Limassol, Cyprus and graduated from the University of West England with a Bachelor’s and a Master’s degree. He then moved to King’s College London to gain post-graduate training in prostate cancer research with Dr Aamir Ahmed’s group. Terry aims to conduct research to identify novel therapies for the treatment of advanced prostate cancer. Ms Karolina Penderecka, also a post-graduate student, is conducting research to identify biomarkers to improve prostate cancer diagnosis. Ms Penderecka is an Erasmus exchange post-graduate student from the University of AdamMickiewicz, Poznań, Poland. She is conducting research on Wnt signaling related quantitative biomarkers of prostate cancer. Dr Josh Kapp, a clinical research fellow, is investigating genetics of prostate cancer. Dr Kapp graduated from the Imperial College London with a B.Sc and completed his MBBS with distinction from King’s College London. He has recently joined an ongoing collaboration with Dr Aamir Ahmed’s group and University College London investigating prostatic diseases. Dr Reena Davda a radiologist has identified a key role for the Wnt signaling pathway in prostate cancer stem like cells as part of her MD thesis. Fiona Watt was awarded a DPhil from Oxford and was a postdoc at MIT. She was a team leader at the Kennedy and for 20 years at CRUK, before helping establish the CRUK Cambridge Research Institute. In 2012 she founded the Centre for Stem Cells and Regenerative Medicine at KCL. She is a Fellow of the Royal Society, in addition to many other honours. She is internationally recognised for her work on stem cells. Dr Matthew Smalley was awarded a PhD at the ICR and then worked at the Hammersmith Hospital, ICR and the Netherlands Cancer Institute. Following research at Breakthrough, he moved to Cardiff in 2012, where he became Deputy Director of the European Cancer Stem Cell Research Institute. His team works on normal and breast cancer stem cells. Immunotherapy Christine Galustian. Christine Galustian was a graduate student at Imperial College, before becoming a MRC non-clinical postdoctoral research fellow. She then led a team at St Georges University of London, investigating mechanisms of action of immunotherapeutic drugs. Christine is now a PCRC senior fellow developing novel immunotherapeutic agents for treating prostate cancer at KCL. In her spare time, she enjoys travelling, music and reading crime novels. Christina Sakellariou. Christina studied Medical Genetics for her first degree and is now a graduate student at KCL, working with Dr Galustian on the development of novel immunotherapy for prostate cancer. She enjoys learning new languages, currently trying not to mix up Spanish and Italian, watching football and travelling. Aradhana Rani. Aradhana was awarded a PhD and continued her postdoctoral studies at KCL London. In 2012, she was awarded a Postdoctoral Investigator Award by the Cytokine Society in Geneva, Switzerland. She is part of the research group of Dr Christine Galustian, Dr Richard Smith and Professor Prokar Dasgupta within the MRC Centre for Transplantation and is also involved in teaching. Efthymia Papaevangelou PhD. Efthymia has a BSc in Biology and an MSc in Cancer Therapeutics. She finished her PhD in Cancer Biology and Imaging in 2013 and moved on to a post-doctoral position where she investigated the efficacy and effects of novel tumour therapies utilising a variety of imaging modalities, including MRI and US. She is currently researching the immunological and biological changes caused by novel immunotherapies on prostate cancer models.